- Xenetic Biosciences Inc XBIO shares dropped 12.6 percent to $2.87.
- Rhythm Pharmaceuticals, Inc. RYTM shares declined 12.2 percent to $26.35. Rhythm Pharmaceuticals priced its 7.05 million share IPO at $17.00 per share.
- Alliqua Biomedical Inc ALQA shares tumbled 10 percent to $3.02. Alliqua Biomedical reported a 1-for-10 reverse stock split.
- Darling Ingredients Inc DAR shares declined 8.9 percent to $16.30. JP Morgan downgraded Darling Ingredients from Overweight to Neutral.
- Inotek Pharmaceuticals Corp ITEK shares fell 8.3 percent to $2.78 after climbing 48.53 percent on Thursday.
- Internap Corp INAP shares dropped 8.3 percent to $4.51.
- Intercept Pharmaceuticals Inc ICPT shares declined 8 percent to $67.00. Seaport Global initiated coverage on Intercept Pharmaceuticals with a Buy rating, while Goldman Sachs resumed coverage on the stock with a Neutral rating.
- Catabasis Pharmaceuticals Inc CATB shares dropped 6.8 percent to $2.65 after declining 6.27 percent on Thursday.
- Sanderson Farms, Inc. SAFM fell 6.2 percent to $150.05. JP Morgan downgraded Sanderson Farms from Neutral to Underweight.
- Costco Wholesale Corporation COST shares dipped 6 percent to $157.15. Costco reported better-than-expected profit for its fourth quarter on Thursday. Morgan Stanley downgraded Costco from Overweight to Equal-Weight.
- HTG Molecular Diagnostics Inc HTGM shares fell 5.3 percent to $1.95.
- Social Reality Inc SRAX shares slipped 5.2 percent to $2.36 after dropping 3.11 percent on Thursday.
- Keane Group Inc FRAC dropped 4.2 percent to $16.48. Barclays initiated coverage on Keane Group with an Underweight rating.
- Triumph Bancorp Inc TBK declined 4.1 percent to $30.90. Piper Jaffray downgraded Triumph Bancorp from Overweight to Neutral.
- Annaly Capital Management, Inc. NLY shares fell 2.5 percent to $12.09. Annaly Capital Management reported a 65 million share offering of common stock.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
